Factors associated with trial recruitment, preferences, and treatments received were elucidated in a comprehensive cohort study.

Factors associated with trial recruitment, preferences, and treatments received were elucidated in a comprehensive cohort study.

<p><strong>Objectives:</strong> Recruitment to pragmatic trials is often difficult, and little is known about factors associated with key participation and treatment decisions. These were explored in the Prostate cancer testing and Treatment (ProtecT) study.</p> <...

Podrobná bibliografie
Hlavní autoři:	Donovan, JL, Opmeer, B, Young, GJ, Mills, N, Martin, RM, Lane, JA, Metcalfe, C, Peters, TJ, Davis, M, Turner, EL, Walsh, E, Neal, DE, Hamdy, FC, ProtecT Study Group
Médium:	Journal article
Jazyk:	English
Vydáno:	Elsevier 2019

Podobné jednotky

A prospective cohort and extended comprehensive-cohort design provided insights about the generalizability of a pragmatic trial: the ProtecT prostate cancer trial
Autor: Donovan, JL, a další
Vydáno: (2017)

Prostate Testing for Cancer and Treatment (ProtecT) feasibility study
Autor: J. Donovan, a další
Vydáno: (2003-01-01)

Modelling the lifetime cost-effectiveness of radical prostatectomy, radiotherapy and active monitoring for men with clinically localised prostate cancer from median 10-year outcomes in the ProtecT randomised trial
Autor: S. Sanghera, a další
Vydáno: (2020-10-01)

Prostate-specific antigen (PSA) testing of men in UK general practice: a 10-year longitudinal cohort study
Autor: Young, GJ, a další
Vydáno: (2017)

Addressing patient treatment preferences at trial recruitment.
Autor: Mills, N, a další
Vydáno: (2011)

Exploring treatment preferences facilitated recruitment to randomized controlled trials
Autor: Mills, N, a další
Vydáno: (2011)

Exploring treatment preferences facilitated recruitment to randomized controlled trials.
Autor: Mills, N, a další
Vydáno: (2011)

Patient-reported outcomes in the ProtecT randomized trial of clinically localized prostate cancer treatments: study design, and baseline urinary, bowel and sexual function and quality of life.
Autor: Lane, A, a další
Vydáno: (2016)

Factors distinguishing general practitioners who more readily participated in a large randomized trial were identified.
Autor: Down, L, a další
Vydáno: (2009)

Addressing patient treatment preferences at trial recruitment
Autor: Mills Nicola, a další
Vydáno: (2011-12-01)

Who can best recruit to randomized trials? Randomized trial comparing surgeons and nurses recruiting patients to a trial of treatments for localized prostate cancer (the ProtecT study).
Autor: Donovan, J, a další
Vydáno: (2003)

Systematic review and meta-analysis of the associations between body mass index, prostate cancer, advanced prostate cancer, and prostate-specific antigen
Autor: Harrison, S, a další
Vydáno: (2020)

The QuinteT Recruitment Intervention supported five randomized trials to recruit to target: a mixed-methods evaluation
Autor: Rooshenas, L, a další
Vydáno: (2018)

A comparison of socio-demographic and psychological factors between patients consenting to randomisation and those selecting treatment (the ProtecT study).
Autor: Mills, N, a další
Vydáno: (2006)

Association of diabetes mellitus with prostate cancer: nested case-control study (Prostate testing for cancer and treatment study).
Autor: Turner, E, a další
Vydáno: (2011)

Radiotherapy for prostate cancer: is it 'what you do' or 'the way that you do it'? A UK perspective on technique and quality assurance.
Autor: Mason, MD, a další
Vydáno: (2016)

Low risk research using routinely collected identifiable health information without informed consent: encounters with the Patient Information Advisory Group.
Autor: Metcalfe, C, a další
Vydáno: (2008)

Informed consent in randomised controlled trials: development and preliminary evaluation of a measure of participatory and informed consent (PIC)
Autor: Wade, J, a další
Vydáno: (2017)

Characteristics of men responding to an invitation to undergo testing for prostate cancer as part of a randomised trial.
Autor: Walsh, E, a další
Vydáno: (2016)

Experiences and decision processes during PSA testing and prostate biopsy: A qualitative study
Autor: Avery, K, a další
Vydáno: (2007)

Seasonal variation in prostate-specific antigen levels: A large cross-sectional study of men in the UK
Autor: Down, L, a další
Vydáno: (2011)

Prostate-specific antigen testing and prostate biopsy: are self-reported lower urinary tract symptoms and health-related quality of life associated with the decision to undergo these investigations?
Autor: Avery, K, a další
Vydáno: (2008)

Do the risk factors of age, family history of prostate cancer or a higher prostate specific antigen level raise anxiety at prostate biopsy?
Autor: Macefield, R, a další
Vydáno: (2009)

Seasonal variation in prostate-specific antigen levels: a large cross-sectional study of men in the UK.
Autor: Down, L, a další
Vydáno: (2011)

Latest results from the UK trials evaluating prostate cancer screening and treatment: the CAP and ProtecT studies.
Autor: Lane, J, a další
Vydáno: (2010)

Fifteen-year outcomes after monitoring, surgery, or radiotherapy for prostate cancer
Autor: Hamdy, FC, a další
Vydáno: (2023)

ProDiet: A phase II randomized placebo-controlled trial of green tea catechins and lycopene in men at increased risk of prostate cancer
Autor: Lane, JA, a další
Vydáno: (2018)

ASSOCIATIONS OF SEXUAL DYSFUNCTION WITH LOCALIZED AND ADVANCED PROSTATE CANCER: A CASE-CONTROL STUDY NESTED WITHIN THE UK POPULATION-BASED PROTECT (PROSTATE TESTING FOR CANCER AND TREATMENT) STUDY
Autor: Collin, S, a další
Vydáno: (2009)

Effect of a low-intensity PSA-based screening intervention on prostate cancer mortality: The CAP randomized clinical trial
Autor: Martin, RM, a další
Vydáno: (2018)

Patient-reported outcomes after monitoring, surgery, or radiotherapy for prostate cancer
Autor: Donovan, J, a další
Vydáno: (2016)

Ethics of clinical trials from bayesian perspective: randomisation to clinical trials may solve dilemma of treatment choice in prostate cancer.
Autor: Hamdy, F, a další
Vydáno: (2003)

The protect trial - Evaluating the effectiveness of treatments for clinically localised prostate cancer and associated molecular and genetic epidemiology studies
Autor: Lane, J, a další
Vydáno: (2007)

Understanding and improving recruitment to randomised controlled trials: Qualitative research approaches.
Autor: Elliott, D, a další
Vydáno: (2017)

Ten-year mortality, disease progression, and treatment-related side effects in men with localised prostate cancer from the protecT randomised controlled trial according to treatment received
Autor: Neal, D, a další
Vydáno: (2019)

Elucidation of Clathrin-Mediated Endocytosis in Tetrahymena Reveals an Evolutionarily Convergent Recruitment of Dynamin.
Vydáno: (2005-11-01)

Elucidation of clathrin-mediated endocytosis in tetrahymena reveals an evolutionarily convergent recruitment of dynamin.
Autor: Nels C Elde, a další
Vydáno: (2005-11-01)

A review of reporting of participant recruitment and retention in RCTs in six major journals
Autor: Tomlin Zelda, a další
Vydáno: (2009-07-01)

Longitudinal prostate-specific antigen reference ranges: Choosing the underlying model of age-related changes
Autor: Simpkin, A, a další
Vydáno: (2013)

Contribution of a single repeat PSA test to prostate cancer risk assessment: experience from the ProtecT study.
Autor: Rosario, D, a další
Vydáno: (2008)

Associations of sexual dysfunction symptoms with PSA-detected localised and advanced prostate cancer: a case-control study nested within the UK population-based ProtecT (Prostate testing for cancer and Treatment) study.
Autor: Collin, S, a další
Vydáno: (2009)